Conventional reverse transcriptase-PCR assay revealed that treatment with VPA did not show significant effect on the mRNA levels of EGFR, ErbB2, and ErbB3 in pancreatic cancer HPAF-II and MPanc96 cells (Fig. 5a). The gene discussed is ERBB3; the disease is familial pancreatic carcinoma.